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Ethnopharmacological relevance 
 Schisandra glaucescens Diels (SGD) is used in a subclass of traditional Chinese medicine 
known as “Tujia drugs”. It has been long used for the treatment of rheumatoid arthritis (RA), 
cough with dyspnea, spontaneous sweating, night sweating, chronic diarrhea, and neurasthenia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Aim of the study: To evaluate the antiarthritic activity of acetate (EA) and n-butanol (Bu) 
fractions of SGD extract on a collagen-induced arthritis mice model. 
Materials and Methods: Acute toxicity of EA and Bu fractions of SGD extract was evaluated 
by gavage on normal mice. Pharmacological investigations were conducted on arthritis male 
Balb/c mice. The animal model was induced by immunization with type II bovine collagen 
(CII) on the 1st and the 14th day of the experimental schedule. EA fraction (104, 312, 936 
mg/kg), Bu fraction (156, 469, 1407 mg/kg) of SGD extract was orally administered every two 
days since the 15th day for 3 weeks. Progression of edema in the paws was measured using a 
vernier caliper every 3 days since the 10th day. At the end of the experiment, the spleen index 
and histological changes of the hind knee joints were investigated. Additionally, to explore the 
possible antirheumatic mechanisms of the EA and Bu fractions, ELISA was carried out to 
analyze TNF-α, IL-10, IL-6 and IL-1β in the serum. 
Results: The half lethal doses of both EA and Bu fractions were much higher than the dose 
administered in the pharmacological investigations. Oral administration of EA fraction and Bu 
fraction of SGD extract significantly and does-dependently inhibited type ІІ collagen induced 
arthritis (CIA) in mice, as indicated by the effects on paws swelling and spleen index. 
Histopathological examinations demonstrated that SGD effectively protected the bones and 
cartilages of knee joints from erosion, lesion and deformation. Besides, the serum 
concentrations of cytokines TNF-α, IL-1β and IL-6 were significantly lower than the ones 
from the vehicle control group. Respectively, while cytokine IL-10 was remarkably higher 
compare with the vehicle control group.  
Conclusions: SGD might be a safe and effective candidate for the treatment of RA, and 
deserves further investigation on the chemical components in both EA and Bu fractions of 
SGD extract. 
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1. Introduction 
Rheumatoid arthritis (RA) is a chronic inflammatory and destructive joint disease that 
affects 0.5–1% of the population worldwide. It usually leads to severe disability and reduces 
the quality of life (Smolen and Steiner, 2003). Initially characterized by an inflammatory 
response of the synovial membrane with hyperplasia and inflammatory cells infiltration, RA 
is characterized as cartilage erosion and bone destruction. The aggressive pannus front invades 
and destroys local articular structures (Firestein, 2003). The cytokines establish a complex 
network whose balance depends on various pathways. Among them, pro-inflammatory 
cytokines such as tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β) and 
interleukin-6 (IL-6), as well as immunoregulatory cytokines such as interleukin-10 (IL-10), 
have been shown to play key roles in pathological mechanism in RA (Hueber and McInnes, 
2007). Particularly, IL-1β was found to be the main mediator of cartilage and bone destruction 
(Joosten et al., 1999). 
Drugs for RA treatment can roughly be divided into three classes: non-steroidal anti-
inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs) and herbal 
medicines. NSAIDs only interfere with a small segment of the inflammatory cascade, namely 
prostaglandin generation by cyclooxygenases, but does not postpone the underlying immuno-
inflammatory events or retard joint destruction (Smolen and Steiner, 2003). Traditional 
DMARDs (such as methotrexate, hydroxychloroquine and sulfasalazine) and biological 
DMARDs (such as tumor necrosis factor antagonists and inerleukin-1 antagonist) have been 
reported to have severe side effects and may lose their treatment effect after prolonged use 
(Maini et al., 1999; Silverstein et al., 2000; Simon, 2000). Herbal medicines with biological 
activities have been widely used to treat bone diseases for thousands of years, and will 
undoubtedly continue to be used as cost-effective alternatives of commercial pharmaceutical 
products. Recently, the therapeutic effect of several traditional herbal medicines on collagen-
induced arthritis has been studied (Chen et al., 2011; Jung et al., 2012; Liu et al., 2012).  
Schisandra glaucescens Diels (SGD) is a woody liana and used as a folk medicine for a long 
history. The stems of SGD, locally called “Huaxueteng” or “Xiangxueteng”, is used in both 
“Tujia drugs” and “Miao drugs” (Xiong et al., 2004; Wan et al., 1990). It has favorable 
therapeutic effects on rheumatoid arthritis, trauma pain and goiter by Chinese medicine 
practices Jianfu or medicated wine (Chinese Materia Midica, 1999). For its long history and 
effective to be used as a folk herbal medicine, several studies had already reported that some 
new bioactive compounds found from this plant, such as lignans with antioxidant and 
neuroprotective properties, cycloartane triterpenoids with effect against FXR and 
estrogen receptor modulators(Yu et al, 2014;Cao et al, 2013; Yu et al, 2012, Zou et al, 2012). 
However, to best our knowledge, its therapeutic effect and its possible bioactive compound on 
RA has not been carefullly investigated in modern ways. Its pharmacological mechanism 
remains unclear. 
 Collagen-induced arthritis (CIA) is an experimental autoimmune disease model, which can 
be elicited in susceptible strains of rodents (rat and mouse) by immunization with type II 
bovine collagen (CII), the major protein constituenof articular cartilage (Rosloniec et al., 2010). 
 It resembles RA in many ways, from genetic linkage to pathology and clinic manifestations 
(Myers et al., 1997). Additionally, among the antigen-defined, cartilage-protein based models, 
it has the shortest duration between immunization and disease manifestation (Brand et al., 
2007). Thus the CIA model is the most widely used one to address questions concerning the 
disease pathogenesis and to elucidate the rationale for a therapy. In the present study, we 
evaluated the therapeutic effects of extract of SGD stem on CIA in Balb/c mice.  
 
2. Materials and Methods 
2.1．Animals 
  Male Balb/c mice, aged 6 weeks, (obtained from the Experimental Animal Center, Tongji 
Medical College, Huazhong University of Science and Technology, China) were maintained 
on a 14/10 hour light/dark cycle (light on 5:00 AM - 7:00 PM: a standard light/dark schedule 
that is used by the university animal care facility) with food and water provided ad libitum 
before initiation of experimental procedures. The mice were housed under standard laboratory 
conditions at an ambient temperature of 22 ± 3  with humidity of 60 ± 5%. All animals were 
handled according to the Guide for the Care and Use of Laboratory Animals published by the 
US National Institute of Health (NIH Publication No. 85 - 23, revised in 1996) and received 
humane care. The experimental rotocols were approved by Huazhong University of Science 
and Technology Committee on Animal Care and Use. 
2.2. Preparation of the extracts and fractions 
  The stems of Schisandra glaucescens Diels were collected from Enshi, Hubei Province, 
People’s Republic of China, in July 2007, and identified by Prof. Dingrong Wan at School of 
Pharmacy, South-Central University for Nationalities (China). A voucher specimen 
(SGD20070805) has been deposited in the Pharmacognosy Laboratory of School of Pharmacy, 
Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China. 
  The dry stems of SGD (10 kg) were powdered and extracted with 95% EtOH under reflux 
(6 h × 3 times). The combined solution was filtered and evaporated to dryness using a rotary 
evaporator (SENCO, Shanghai, China) under reduced pressure. The extract was then 
suspended in water and successively partitioned with ethyl acetate (EA) and n-butanol (Bu). 
The EA fraction and Bu fraction were dried with a vacuum dryer to obtain the EA (260 g) and 
Bu (391 g) fractions. The w/w extraction yields for the EA and Bu fractions of the dried SGD 
were 2.6% and 3.91% respectively. The fractions were kept at 4 °C. 
   The standardization of SGD EA and Bu fractions can be seen in Supplementary Material. 
2.3. Acute oral toxicity study 
  To evaluate the acute oral toxicity of EA and Bu fractions, 15 male and 15 female mice 
randomly assigned to 3 experimental groups and the method referring to a description by 
Walum (1998) was used. The single-dose toxicity of EA fraction and Bu fraction were 
investigated at the dose of 4.6 g/kg and 7.82 g/kg body weight, respectively, both equal to 200 
g dry stems per kilogram body weight. The dose was the maximum feasible dose (refer to 
Diehl KH et al, 2001, J. Appl. Toxicol. 21, 15-23) that we could take: administration volumes 
considered good practice (0.1ml/10g mouse refer to Diehl KH et al, 2001, J. Appl. Toxicol. 21, 
15-23) and the highest solubility of both compounds in the 0.5% Caboxy Methyl Cellulose 
(CMC-Na) solution. The control group was orally treated with 0.5% CMC-Na. Mortality, 
body weight and general behaviors were monitored during 14 days. 
2.4. Induction of CIA and drug administration 
   For a more detailed explanation on how to induce CIA, refer to a protocol by Brand et al., 
(2007). Briefly, the normal group consisting of 10 mice was randomly assigned before the 
experiment without immunization, while the model and treatment groups were immunized as 
follows. Bovine type II collagen (Chondrex, USA) was dissolved in 0.1M acetic acid at a 
concentration of 2 mg/ml and kept at 4  overnight, and then it was emulsified with an equal 
volume of Freund’s complete adjuvant (CFA) (Sigma, USA) to a final CII concentration of 1 
mg/ml. On the 1st day of the experiment, all mice were intradermally injected at several sites 
at the base of the tail with the CII emulsion, with 0.1 ml per mice, as the primary immunization. 
Two weeks after the primary immunization (on the 14th day), the mice were challenged again 
by injecting the same volume of CII emulsion at the same location. 
  Testing mice were randomly divided into 10 groups (n = 10 per group) and defined as 
following: Normal group as negative control for CIA, model group as positive control for 
disease induced, of other 8 tested groups, two groups as positive treatment control and treated 
with dexamethasone(Dex) or Tripterygium glycosides (TGs) respectively, 3 groups treated 
with different dose of stem extraction from EA fraction and 3 groups treated with different 
dose of stem extraction from Bu fraction. The normal group was orally treated with distilled 
water containing 0.5% CMC-Na (0.1 ml/10 g body weight). Dex treatment groups were treated 
orally with dexamethasone (Dex) (3 mg/kg body weight) (Earp et al., 2008; Kang et al., 2000) 
and corresponding for TGs treatment group was TGs (60 mg/kg body weight) (Wan et al., 
2013). Each fraction was administered at three doses according to the conversion tables of 
dose relationship between humans and mice (Shaw et al., 2008). Specifically, the doses were 
140, 312 and 936 mg/kg for EA fraction and 156, 469 and 1407 mg/kg for Bu fraction in mice, 
which were equivalent to 4, 12 and 36 g dried stems per every kilo of human body weight. All 
groups were administered orally with vehicle, Dex, TGs, EA or Bu fractions once every 2 days 
beginning on the 15th day for 3 weeks (time schedule detailed in Fig.1).  
 
Fig.1. Chart for experimental design 
 
2.5. Measurement of paw edema progression 
  From the 10th day following the primary immunization, the thickness of the right hind paw 
was measured every 3 days with a Vernier calliper (GBT1214-1986, Shanghai) by an 
independent operator without prior knowledge of the experimental groups. Each paw was 
measured three times on each day, and the average was calculated as the final value as an 
indicator of the progression of CIA. 
2.6. Measurement of spleen index 
  At the end of the experiment, all mice were sacrificed by cervical dislocation after serum 
sample collection. Their spleens were weighed immediately after dissection. The spleen 
indexes were calculated referring to Zhang’s study (Zhang et al, 2004), by using the following 
formula: Spleen Index = Spleen weight / Body weight. 
2.7. Analysis of histopathology 
  For histological analysis of knee joints, the right hind limbs of mice were removed 
postmortem and fixed in 4% paraformaldehyde for 24 h, decalcified with 12.5% ethylene 
diamine tetraacetic acid (EDTA, pH 7.0) for 15 days, embedded in paraffin, and then sectioned 
at the sickness of 6–8 μm thickness. Tissue sections were stained with hematoxylin and eosin 
prior to observation by light microscopy (Leica, DM2500, Germany). Infiltration of 
inflammatory cells, proliferation of synoviocyte, pannus formation, joint space change, 
cartilage hyperplasia and/or erosion, and bone destruction were blindly graded by a pathologist 
and assigned scores between 0–3 based on the following criteria: 0, no changes; 1, mild 
changes; 2, moderate changes; 3, severe changes (Seeuws et al., 2010).  
2.8. Detection of serum cytokine level by ELISA 
  The levels of TNF-α, IL-1β, IL-6 and IL-10 in serum samples were measured by 
commercially available enzyme-linked immunosorbent assay kits (ELISA) following the 
standard kit protocol. The kits and the type of ELISA used for the study were Mouse TNF-
alpha Quantikine ELISA Kits (R&D Systems Inc., USA), Mouse IL-1 beta Quantikine ELISA 
Kits (R&D Systems Inc., USA), Mouse IL-6 Quantikine ELISA Kits (R&D Systems Inc., 
USA), and Mouse IL-10 Quantikine ELISA Kits (R&D Systems Inc., USA). The 
concentrations of these cytokines were calculated from the respective standard curves. 
2.10．Statistical analysis 
  All data analysis was completed using the Graphpad PRISM version 5.0 software and IBM 
SPSS Statistics 19 software. Data are expressed as mean ± SEM. All neurochemical data were 
analyzed by one way analysis of variance (ANOVA) followed by Tukey’s post hoc analysis. 
Histopathological score data were analyzed by Kruskal-Wallis H test followed by Nemenyi 
test. P values lower than 0.05 were considered statistically significant. 
3. Results 
3.1. Acute oral toxicity of EA and Bu fractions of SGD extract 
To test the acute toxicity of EA and Bu fractions from SGD, an extremely high dose was 
administered to normal mice by gavage. The mortality, body weight and general behaviors 
were monitored for 14 days. No mice died after gavage administration of EA and Bu fractions. 
For this reason, we did not get the half lethal dose for either EA or Bu fraction. When 
comparing normal mice with those were received Bu (7.82 g/kg) or EA (4.6 g/kg) 
administration, there was no significant difference in activity and general behaviors for both 
males and females. These results suggest that the Bu fraction of SGD extract were not toxic in 
vivo at the studied dose. The half lethal doses of both EA and Bu fractions are much higher 
than the doses we investigated in activity tests. Thus both EA and Bu fractions of SGD extract 
could be safely used in the following study.  
  
3.2. SGD extracts reduced collagen-induced arthritis on mice  
The changes of paw thickness from the 10th to the 34th day are displayed in Table 1. As 
expected, the hind paws of the CIA model mice significantly swelled from day 19 to the end 
of the experiment compared with normal mice (all P < 0.01). Compared with the CIA model 
group, the paw swelling of EA (104 mg/kg) treated group was significantly ameliorated from 
day 25 (all P < 0.01), the pawing swelling of EA (312 mg/kg) treated group was inhibited 
from day 22 (all P < 0.01), and the paw swelling of EA (936 mg/kg) treated group was 
ameliorated from day 19 (all P < 0.01). For Bu (156, 469, 1407 mg/kg) treated groups, paw 
swelling was significantly reduced respectively on days 25, 22 and 19, respectively, compared 
with the CIA model group (all P < 0.01). Importantly, the edema inhibition effect of EA (936 
mg/kg) and Bu (1407 mg/kg) occurred earlier than TGs (60 mg/kg). 
The increased spleen index in RA disease reflects an enlarged spleen. The spleen index of 
the CIA model mice significantly increased compared with normal mice (P < 0.01). 
However, spleen indexes of CIA mice treated with SGD were suppressed when compared 
with the model group (Fig.2). Compared with the model group, groups treated with EA (936 
mg/kg) and Bu (156, 469, 1407 mg/kg) displayed significantly decreased spleen index (P < 
0.01). EA (312 mg/kg) also showed decreased spleen index compared with CIA model group 
(P < 0.05). 
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Fig.2. Effects of SGD on the spleen indexes on CIA mice. Data 
were analyzed by one-way ANOVA followed by Tukey’s post 
hoc analysis. Values represent mean ± SEM (n = 10), # P < 0.05, 
## P < 0.01 compared with the model group. Model male Balb/c 
mice only received 0.5% CMC-Na orally.  
 
Table 1 
Effects of ethyl acetate and n-butanol fractions of Schisandra glaucescens Diels extract on hind paw swelling in CIA mice 
Groups The changes of hind paw swelling (cm) 
(mg/kg) Day10 Day13 Day16 Day19 Day22 Day25 Day28 Day31 Day34 
Normal 0.218±0.003 0.219±0.004 0.221±0.004 0.224±0.003## 0.226±0.002## 0.226±0.002## 0.221±0.004## 0.223±0.002## 0.226±0.003## 
Model 0.228±0.003 0.235±0.004 0.244±0.004 0.252±0.003 0.261±0.004 0.266±0.002 0.266±0.003 0.268±0.002 0.265±0.002 
Dex (3) 0.227±0.004 0.226±0.004 0.222±0.004## 0.217±0.004## 0.220±0.004## 0.217±0.004## 0.214±0.004## 0.217±0.004## 0.217±0.003## 
TGs (60) 0.232±0.003 0.232±0.003 0.244±0.005 0.230±0.005# 0.230±0.008## 0.238±0.004## 0.251±0.006## 0.232±0.005## 0.230±0.003## 
EA (104) 0.230±0.003 0.235±0.004 0.238±0.003 0.236±0.004 0.238±0.003# 0.239±0.007## 0.235±0.004## 0.239±0.005## 0.240±0.004## 
EA (312) 0.227±0.003 0.231±0.004 0.233±0.004 0.235±0.004 0.232±0.006## 0.229±0.007## 0.228±0.004## 0.227±0.004## 0.229±0.006## 
EA (936) 0.227±0.005 0.236±0.005 0.241±0.004 0.228±0.005## 0.230±0.005## 0.222±0.005## 0.225±0.004## 0.229±0.002## 0.221±0.002## 
Bu (156) 0.227±0.002 0.228±0.002 0.239±0.003 0.238±0.005 0.241±0.006 0.225±0.007## 0.236±0.005## 0.236±0.005## 0.233±0.003## 
Bu (469) 0.226±0.004 0.229±0.004 0.237±0.004 0.229±0.004# 0.227±0.005## 0.220±0.004## 0.228±0.004## 0.229±0.004## 0.224±0.004## 
Bu (1407) 0.229±0.002 0.233±0.003 0.235±0.003 0.226±0.004## 0.227±0.004## 0.218±0.005## 0.221±0.002## 0.225±0.002## 0.223±0.003## 
    Data were analyzed by one-way ANOVA followed by Tukey’s post hoc analysis. Values represent mean ± SEM (n=10). 
 # P<0.05, ## P<0.01 compared with model group
 
To determine whether SGD prevented articular destruction, hind knee joints of CIA mice 
were investigated by histological examination (Figs.3-6). Non-immunized mice showed 
normal articular cartilage, absence of infiltrate in the synovium and open joint space (Fig. 3A). 
As shown in Fig. 3B, the knee joints of induced arthritis model showed typical pathological 
changes with inflammatory cell infiltration, various degrees of hyperplastic synovium, 
formation of pannus, cartilage hyperplasia and erosion, and severely narrow joint space. 
Groups treated with EA (936 mg/kg) and Bu (1407 mg/kg) had considerably reduced signs of 
disease severity (Figs. 5G and 6J). A small increase in synovial cell infiltration and/or cartilage 
hyperplasia were detected in the joints of mice receiving EA (312 mg/kg) and Bu (469 mg/kg), 
but little or no discernable pannus formation and cartilage erosion were observed in the knee 
joints (Figs. 5F and 6I). Moderate inflammatory cell infiltration, slight pannus formation and 
hyperplasia synovium were seen in the joints of animals treated with EA (140 mg/kg) and Bu 
(156 mg/kg) (Figs. 5E and 6H). 
To evaluate and quantify the severity of histological changes, a score system described 
before (Seeuws et al., 2010) was used. As shown in Table 2, the pathological score of the 
model group was significantly higher than the normal group (P < 0.01). EA (312, 936 mg/kg) 
treated groups showed obvious changes (all P < 0.05). Meanwhile, Bu (469, 1407 mg/kg) 
fraction was effective in preventing destruction of joint (all P < 0.05).  
These results indicate that both EA and Bu fractions from SGD successfully slowed down 
the development of collagen induced arthritis in mice.  
 
Table 2 
Effects of SGD on histopathological score in CIA mice 
Groups 
(mg/kg) 
Number of mice in each histopathological score P values (compared 
with model group) 0 1 2 3 
Normal 9 1 0 0 0.001 
Model 0 0 3 7 – 
Dex (3) 4 5 1 0 0.029 
TGs (60) 5 5 0 0 0.016 
EA (104) 0 3 2 5 0.097 
EA (312) 1 6 3 0 0.037 
EA (936) 4 4 2 0 0.029 
Bu (156) 0 3 6 1 0.072 
Bu (469) 1 6 3 0 0.029 
Bu (1407) 6 4 0 0 0.029 
Data were analyzed by Kruskal-Wallis H test followed by Nemenyi test. Histopathological scores: 0, no 
changes; 1, mild changes; 2, moderate changes; 3, severe changes. There’s significant difference between 
groups.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3. Histology changes of joints from the normal group and the model group mice: (A) Normal group mice showed 
the normal articular cartilage, absence of damage in the synovium and open joint space; (B) Model group mice showed 
marked infiltration of inflammatory cells and synovial hyperplasia.  , cartilage hyperplasy and erosion; , 
synovia hyperplasia; , inflammatory cell infiltration; , pannus formation. 
   
   
  
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
  
 
  
 
 
Fig.4. Histology changes of joints from the the Dex and TGs treated mice: (C) 3mg/kg Dex treated mice; (D) 
60mg/kg TGs treated mice; Both groups showed mild histology changes of arthritis and open joint space;  , 
cartilage hyperplasy and erosion; , synovia hyperplasia; , inflammatory cell infiltration; , pannus 
formation. 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5. Histology changes of joints from EA treated mice: (E) 140 mg/kg treated mice. (F) 321 mg/kg EA treated 
mice. (G) 936 mg/kg treated mice. From figure E to G showed that EA could decrease the histology changes on 
collegen induced arthritis in a dose dependent manner.  , cartilage hyperplasy and erosion; , synovia 
hyperplasia; , inflammatory cell infiltration; , pannus formation. 
 
   
   
 
 
 
 
 
3.3. Effect on serum level of TNF-α, IL-10, IL-6 and IL-1β 
To explore the possible antirheumatic mechanism of both EA and Bu fractions, blood 
samples were collected immediately after cervical dislocation. The levels of TNF-α, IL-10, IL-
6 and IL-1β in serum were analyzed by ELISA.  
The results (see Fig.7A, 7C, 7D) demonstrated that the serum level of TNF-α, IL-6 and IL-
Fig.6. Histology changes of joints from Bu treated mice: (H) 156mg/kg Bu treated mice. (I) 469 mg/kg Bu treated 
mice. (J) 1407 mg/kg Bu treated mice. From figure H to J showed that Bu could decrease the histology changes on 
collegen induced arthritis in a dose dependent manner.  , cartilage hyperplasy and erosion; , synovia 
hyperplasia; , inflammatory cell infiltration; , pannus formation. 
   
   
1β remarkably increased in the CIA model mice (all P < 0.01). Compared with CIA mice, the 
TNF-α, IL-6 and IL-1β levels in mice treated with either EA (312, 936 mg/kg) or Bu (469, 
1407 mg/kg) fraction were significantly decreased (all P < 0.01). EA (104 mg/kg) fraction also 
reduced the TNF-α level effectively (P < 0.01). The serum level of IL-6 was decreased in mice 
treated with low dose of EA (104 mg/kg) (P < 0.01) and Bu (156 mg/kg) (P < 0.01) fractions. 
As shown in Fig.7B, the serum level of IL-10 in CIA mice was sharply decreased (P < 0.01). 
The IL-10 level of mice treated with EA (312, 936 mg/kg) and Bu (469, 1407 mg/kg) fractions 
was clearly increased compared with the model group (all P < 0.01). All dosages of EA (104, 
312, 936 mg/kg) fraction showed an effect on serum TNF-α and IL-6 levels. Similarly, all 
dosages of Bu (156, 469, 1407 mg/kg) fraction showed an effect on serum IL-10 and IL-6 
levels. 
These results demonstrate that the pathway of cytokine synthesis may be involved in the 
antirheumatic effect of both EA and Bu fractions of SGD extract.  
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Fig.7. Levels of serum TNF-α, IL-10, IL-6 and IL-1β in mice (mean ± SEM., n = 10). Data were analyzed by one-way 
ANOVA followed by Tukey’s post hoc analysis. Values represent mean ± SEM (n = 10), # P < 0.05, ## P < 0.01, ### P < 
0.005 compared with the model group. 
 
4. Discussion 
  Rheumatoid arthritis (RA) is an autoimmune and chronic inflammatory disorder that 
primarily targets the synovial membrane, cartilage and bone. CIA is an established 
experimental model of polyarthritis with many histopathological features similar to RA (Di 
Paola and Cuzzocrea, 2008) and thus extensively used to study the disease pathogenesis and 
potential therapies. As a traditional folk medicine, Schisandra glaucescens Diels (SGD) has 
been long used to treat rheumatic arthritis in Enshi, Hubei, China. Our study demonstrated that 
EA and Bu fractions of SGD had an obvious therapeutic effect on CIA mice with extremely 
low toxicity. 
In the present study, both EA and Bu fractions showed extremely low toxicity. After 
treatment with the highest dose that can be suspended in CMC-Na (200 g/kg body weight, 
equivalent to the dry stems), no mice died or showed any abnormal behaviors or body-weight 
loss. As a result, the treatment doses of EA and Bu fractions are much lower than the half 
lethal dose. This study also indicated that SGD is a safe herbal medicine for treating RA.  
We have demonstrated that the oral administration of both the EA and Bu fraction of SGD 
extract effectively and dose-dependently suppress the paw edema in Balb/c mice. The spleen 
is an important immune organ in the body. Since RA is induced by auto-immune regulative 
disorders, the spleen is supposed to be influenced in the process of RA. In our study, Bu and 
EA fractions effectively reduced the spleen index of CIA mice, especially EA at the dose of 
936 mg/kg and all doses of Bu fraction. From the histopathological point, EA and Bu fractions 
visibly inhibited synovial hyperplasia, inflammatory cell infiltration, pannus formation and 
cartilage erosion. 
This study indicates that SGD inhibits arthritis via a variety of ways. EA and Bu fractions 
decreased the serum levels of TNF-α, IL-6 and IL-1β and increased the level of IL-10. As a 
proinflammatory cytokine, TNF-α plays a special role in the regulation of other equally strong 
proinflammatory cytokines e.g. IL-1, IL-6, IL-8 and granulocyte-macrophage colony-
stimulating factors (Brand et al., 2007; Feldmann et al., 1996). With the assistance of the 
receptor or activator of NF-κB ligand (RANKL), TNF-α markedly potentiate NF-κB and 
stress-activated protein kinase/c-Jun NH2-terminal kinase activity, two signaling pathways 
essential for osteoclastogenesis (Lam et al., 2000). The efficacy of anti-TNF-α agents such as 
infliximab and etanercept in the treatment of RA has been demonstrated in large-scale trials 
(Lipsky et al., 2000; Maini et al., 1999; Moreland et al., 1999). IL-1β is the key mediator with 
regard to cartilage and bone destruction. Blockage of IL-1, either after onset or during 
established CIA, effectively suppresses the arthritic process (Joosten et al., 1999). In the acute 
phase of RA, IL-6 obviously increases and its increase positively relates to the damage of 
joints. Meanwhile, IL-10 has been regarded as upstream regulators that control the progression 
of RA negatively (Apparailly et al., 1998). The various functions of IL-10 include down-
regulation of co-stimulatory molecules and the class II MHC molecule, prevention of 
inflammatory mediator secretion, inhibition of cytokine secretion from T cells, induction of 
anergy of T cells, and promotion of the differentiation and survival of B cells (de Waal et al., 
1991; Groux et al., 1998). IL-10 not only inhibit the biosynthesis of cytokines produced by 
Th1 cells, such as IFN-γ, TNF-α, IL-1 and GM-CSF, but also inhibit IL-18 mRNA expression 
(Marshall et al., 1999). The therapeutic effect of SGD appears to be related to its modulation 
of the key cytokines in RA pathogenesis, including decreasing the levels of TNF-α, IL-6, IL-
1β and increasing the level of IL-10 in the serum of CIA mice. In the present study, the level 
of IL-1β was significantly decreased in the serum of CIA mice after the oral administration of 
EA (312, 936 mg/kg) or Bu (469, 1407 mg/kg) fraction. The drawdown of IL-1β is caused not 
only by the direct effect of SGD, but also by the decreased TNF-α and increased IL-10. 
Consequently, modulating the key cytokines in RA process was speculated to be one of the 
anti-RA mechanisms of SGD. 
In conclusion, EA and Bu fractions of SGD had an obvious therapeutic effect on CIA mice 
with extremely low toxicity. It is deserve to further screen the active compounds in SGD 
extract, and to explore the exact mechanism of the anti-arthritis activity. 
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Appendix A. Abbreviations 
Bu       Fractions extracted by n-butyl alcohol 
CIA      collagen-induced arthritis 
CII       type II bovine collagen 
Dex      dexamethasone 
EA       Fractions extracted by ethylacetate 
ELISA    enzyme-linked immunesorbent assay kit 
IL-1β     interleukin 1 beta 
IL-6      interleukin 6 
IL-10     interleukin 10 
RA       rheumatoid arthritis 
RANKL   receptor or activator of NF-KB ligand  
SGD      Schisandra glaucescens Diels 
TGs      Tripterygium Glycosides  
TNF-α    tumor necrosis factor alpha 
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Figure legend 
 
Fig.1. Chart for experimental design 
Fig.2. Effects of SGD on the spleen indexes on CIA mice. Data were analyzed by one-way ANOVA followed by Tukey’s 
post hoc analysis. Values represent mean ± SEM (n = 10), # P < 0.05, ## P < 0.01 compared with the model group. Model 
male Balb/c mice only received 0.5% CMC-Na orally.  
 
Fig.3. Histology changes of joints from the normal group and the model group mice: (A) Normal group mice showed the 
normal articular cartilage, absence of damage in the synovium and open joint space; (B) Model group mice showed marked 
infiltration of inflammatory cells and synovial hyperplasia.  , cartilage hyperplasy and erosion; , synovia 
hyperplasia; , inflammatory cell infiltration; , pannus formation. 
 
Fig.4. Histology changes of joints from the the Dex and TGs treated mice: (C) 3mg/kg Dex treated mice; (D) 60mg/kg TGs 
treated mice; Both groups showed mild histology changes of arthritis and open joint space;  , cartilage hyperplasy and 
erosion; , synovia hyperplasia; , inflammatory cell infiltration; , pannus formation. 
 
Fig.5. Histology changes of joints from EA treated mice: (E) 140 mg/kg treated mice. (F) 321 mg/kg EA treated mice. (G) 
936 mg/kg treated mice. From figure E to G showed that EA could decrease the histology changes on collegen induced arthritis 
in a dose dependent manner.  , cartilage hyperplasy and erosion; , synovia hyperplasia; , inflammatory cell 
infiltration; , pannus formation. 
 
Fig.6. Histology changes of joints from Bu treated mice: (H) 156mg/kg Bu treated mice. (I) 469 mg/kg Bu treated mice. (J) 
1407 mg/kg Bu treated mice. From figure H to J showed that Bu could decrease the histology changes on collegen induced 
arthritis in a dose dependent manner.  , cartilage hyperplasy and erosion; , synovia hyperplasia; , inflammatory 
cell infiltration; , pannus formation. 
 
Fig.7. Levels of serum TNF-α, IL-10, IL-6 and IL-1β in mice (mean ± SEM., n = 10). Data were analyzed by one-way 
ANOVA followed by Tukey’s post hoc analysis. Values represent mean ± SEM (n = 10), # P < 0.05, ## P < 0.01, ### P < 
0.005 compared with the model group. 
   
   
 
     
     
 
     
 
